logo


Home Diagnostics to Present at Noble Financial Fifth Annual Equity Conference
Thursday, June 04, 2009 6:00 PM


Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that Ronald Rubin, Chief Financial Officer of Home Diagnostics, is scheduled to present at the Noble Financial Fifth Annual Equity Conference at the Seminole Hard Rock Hotel and Casino in Hollywood, FL, on Monday, June 8, 2009, at 3:05 p.m. ET.

A live Web cast of the presentation will be available on the Home Diagnostics Web site at www.homediagnostics.com. A replay of the Web cast will be available following the live presentation and will remain on the site for 30 days.

About Home Diagnostics, Inc.

Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ: HDIX) is a leading developer, manufacturer and marketer of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go™, TRUEresult™, TRUEbalance™, TRUEtrack®, Sidekick®, TRUEread™ and Prestige Smart System® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens as well as national distributors such as AmerisourceBergen, Cardinal Health, McKesson and Invacare. Home Diagnostics, Inc. was named one of Forbes magazine’s “200 Best Small Companies” in 2008. For more information please visit www.homediagnostics.com.

TRUE2go, TRUEresult, TRUEtest, TRUEbalance, TRUEtrack, Sidekick, TRUEread and Prestige Smart System are trademarks of Home Diagnostics, Inc. All other trademarks are property of their respective owners.

[HDIX-F]

Home Diagnostics
Sabrina Rios, Corporate Communications Manager, 954-332-2141
srios@hdidiabetes.com
or
The Ruth Group
Nick Laudico (investors), 646-536-7030
nlaudico@theruthgroup.com

(Source: Business Wire )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia